Board Change • May 20
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO & Chair of the Board Lavrans Grjotheim was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Feb 24
Hynion AS Approves Election of Lavrans Grjotheim as New Chair, Effective 24 February 2026 Hynion AS at its extraordinary general meeting held on 24 February 2026, approved the election of Lavrans Grjotheim as the new chair. Board Change • Oct 01
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Chair of the Board Jens Myhrstad was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jul 28
Hynion as Announces Board Changes Hynion AS in its extraordinary general meeting held on 25 July, 2025 resolved the election of new board of directors. The Board now comprises: Jens Myhrstad, Chair of the board. Johan Mathias Lund Solli, Board Member. Leo Sebastian Meisingseth- Montarou, Board Member. All members were elected for a period of two years. Announcement • Jun 25
Hynion AS to Report Fiscal Year 2024 Results on Aug 29, 2025 Hynion AS announced that they will report fiscal year 2024 results on Aug 29, 2025 Announcement • May 28
Hynion AS has filed a Follow-on Equity Offering. Hynion AS has filed a Follow-on Equity Offering.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 9,291,585 Announcement • Apr 26
Hynion AS Announces CFO Changes Hynion AS announces that Vibeke Schønfeldt has stepped down from her role as Chief Financial Officer (CFO). Elisabeth Amnell has been appointed interim CFO until a permanent successor is in place. Vibeke Schønfeldt left her position after completing the handover to Elisabeth Amnell. The recruitment process for a new permanent CFO is ongoing. New Risk • Apr 04
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (kr6.3m revenue, or US$601k). Market cap is less than US$10m (kr9.06m market cap, or US$859.7k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). New Risk • Dec 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr11m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (kr6.3m revenue, or US$568k). Market cap is less than US$10m (kr18.2m market cap, or US$1.63m). New Risk • Oct 17
New major risk - Revenue and earnings growth Earnings have declined by 23% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr11m free cash flow). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (kr6.3m revenue, or US$580k). Market cap is less than US$10m (kr30.9m market cap, or US$2.83m). Minor Risk Share price has been volatile over the past 3 months (9.3% average weekly change). New Risk • Sep 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Revenue is less than US$1m (kr4.6m revenue, or US$437k). Market cap is less than US$10m (kr30.0m market cap, or US$2.83m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.6% average weekly change). Announcement • Aug 28
Hynion AS, Annual General Meeting, Apr 03, 2025 Hynion AS, Annual General Meeting, Apr 03, 2025. Announcement • Aug 26
Hynion AS to Report Fiscal Year 2024 Results on Mar 06, 2025 Hynion AS announced that they will report fiscal year 2024 results on Mar 06, 2025 Reported Earnings • Mar 03
Full year 2023 earnings released Full year 2023 results: Revenue: kr4.63m (up 11% from FY 2022). Net loss: kr32.2m (loss widened 10% from FY 2022). New Risk • Oct 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Norwegian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr49m free cash flow). Shareholders have been substantially diluted in the past year (92% increase in shares outstanding). Revenue is less than US$1m (kr4.7m revenue, or US$435k). Market cap is less than US$10m (kr28.8m market cap, or US$2.66m). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Reported Earnings • Sep 17
First half 2023 earnings released: kr0.17 loss per share (vs kr0.28 loss in 1H 2022) First half 2023 results: kr0.17 loss per share. Revenue: kr2.25m (up 34% from 1H 2022). Net loss: kr18.0m (loss widened 13% from 1H 2022). Announcement • Aug 30
Building Committee Approves Building Permit for Hynion's Hydrogen Refueling Station in Vasteras Hynion AS announced that the building committee in Vasteras has decided to grant Hynion a building permit for the new construction of a hydrogen refueling station at the STOP128 truck stop in Vasteras. It is one of two stations for which Hynion has been granted a grant from the Swedish Energy Agency and which is to be completed in January 2024. As previously communicated, Hynion has been granted a grant of SEK 61.4 million from the Swedish Energy Agency to build two hydrogen refueling stations with a capacity of 1,500 kg of hydrogen per day. One station is to be built in Västerås, at the STOP128 truck stop, right next to the E18, and the other station is to be built in the Torsvik logistics area in Jönköping. Both stations are to be completed in January 2024. Reported Earnings • Mar 04
Full year 2022 earnings released Full year 2022 results: Net loss: kr29.2m (loss widened 74% from FY 2021). Announcement • Feb 03
Hynion as Announces Resignation of Ulf Hafseld from the Board Hynion AS announced that the board member Ulf Hafseld has resigned from the board with immediate effect. Announcement • Jan 31
Hynion AS Announces Chief Executive Officer Changes The board of Hynion AS appointed Slavica Djuric as acting interim CEO, effective January 30, 2023. During Slavica Djuric interim period as CEO, she will remain as CEO of the Company's subsidiary Hynion Sverige AB and head of Investor Relations. The Company has initiated the recruitment process for a new permanent CEO. Slavica Djuric succeeds Ulf Hafseld, who leaves his position with immediate effect, but will be at the board's disposal during the notice period. The board will call an extraordinary general meeting as soon as possible to decide on changes to the board. The appointment of a new CEO for Hynion AS is part of a larger strengthening within the Group, prompted by the fact that Hynion Sverige AB received partial financing of significant projects within Sweden's hydrogen infrastructure. This requires a considerable effort by Hynion Sweden. Announcement • Jan 04
Hynion AS to Report First Half, 2023 Results on Sep 15, 2023 Hynion AS announced that they will report first half, 2023 results on Sep 15, 2023 Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Chairman of the Board Lars Amnell was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 17
First half 2022 earnings released First half 2022 results: kr0.28 loss per share. Net loss: kr15.8m (flat on 1H 2021). Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Chairman of the Board Lars Amnell was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 20
Hynion AS to Report Fiscal Year 2022 Results on Mar 01, 2023 Hynion AS announced that they will report fiscal year 2022 results on Mar 01, 2023